Statins and Pregnancy - New FDA Recommendations.
作者信息
Bittencourt Marcio Sommer
机构信息
Division of Cardiology, Department of Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh - EUA.
出版信息
Arq Bras Cardiol. 2022 Jul;119(1):1-2. doi: 10.36660/abc.20220413.
Abstract
摘要
相似文献
1
Statins and Pregnancy - New FDA Recommendations.他汀类药物与妊娠——美国食品药品监督管理局的新建议
Arq Bras Cardiol. 2022 Jul;119(1):1-2. doi: 10.36660/abc.20220413.
2
Statins: beware during pregnancy.他汀类药物：孕期慎用。
Prescrire Int. 2006 Feb;15(81):18-9.
3
Statins in pregnancy: new safety data are reassuring, but suspension of treatment is still advisable.孕期使用他汀类药物：新的安全性数据令人安心，但仍建议暂停治疗。
BMJ. 2015 Mar 17;350:h1484. doi: 10.1136/bmj.h1484.
4
Statins are detrimental to human placental development and function; use of statins during early pregnancy is inadvisable.他汀类药物对人类胎盘发育和功能有害；孕期早期使用他汀类药物是不可取的。
J Cell Mol Med. 2008 Dec;12(6A):2295-6. doi: 10.1111/j.1582-4934.2008.00466.x.
5
Statins in pregnancy: safety and perspectives of therapeutic applications.孕期使用他汀类药物：治疗应用的安全性及前景
BJOG. 2013 Oct;120(11):1439-40. doi: 10.1111/1471-0528.12279.
6
The fetal safety of statins: a systematic review and meta-analysis.他汀类药物的胎儿安全性：一项系统评价与荟萃分析。
J Obstet Gynaecol Can. 2014 Jun;36(6):506-509. doi: 10.1016/S1701-2163(15)30565-X.
7
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.作者对《孕期他汀类药物：治疗应用的安全性与前景》的回应
BJOG. 2013 Oct;120(11):1440. doi: 10.1111/1471-0528.12280.
8
Statins and pregnancy: between supposed risks and theoretical benefits.他汀类药物与妊娠：风险与潜在益处之间的权衡。
Drugs. 2012 Apr 16;72(6):773-88. doi: 10.2165/11632010-000000000-00000.
9
Statins.他汀类药物。
J Obstet Gynaecol Can. 2003 Mar;25(3):231-4. doi: 10.1016/s1701-2163(16)30111-6.
10
[Adverse drug reactions of hydroxymethylglutaryl-CoA reductase inhibitors reported to agency for medicinal products and medical devices].[向药品和医疗器械机构报告的羟甲基戊二酰辅酶A还原酶抑制剂的药物不良反应]
Lijec Vjesn. 2010 Sep-Oct;132(9-10):277-82.
引用本文的文献
1
Clinical repercussions of statin use during pregnancy: a review of the literature.孕期使用他汀类药物的临床影响：文献综述
Rev Bras Ginecol Obstet. 2025 Mar 17;47. doi: 10.61622/rbgo/2025rbgo2. eCollection 2025.
本文引用的文献
1
Pregnancy outcomes following maternal exposure to statins: A systematic review and meta-analysis.他汀类药物暴露对母代妊娠结局的影响：系统评价和荟萃分析。
Br J Clin Pharmacol. 2022 Sep;88(9):3962-3976. doi: 10.1111/bcp.15423. Epub 2022 Jun 10.
2
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia.女性家族性高胆固醇血症患者在怀孕期间和哺乳期他汀类药物治疗年数的损失。
Atherosclerosis. 2021 Oct;335:8-15. doi: 10.1016/j.atherosclerosis.2021.09.003. Epub 2021 Sep 3.
3
Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia.普伐他汀与安慰剂在有发生足月子痫前期高危风险的妊娠中的应用比较。
Circulation. 2021 Aug 31;144(9):670-679. doi: 10.1161/CIRCULATIONAHA.121.053963. Epub 2021 Jun 24.
4
Trends in time-to-pregnancy in the USA: 2002 to 2017.美国的妊娠时间趋势：2002 年至 2017 年。
Hum Reprod. 2021 Jul 19;36(8):2331-2338. doi: 10.1093/humrep/deab107.
5
Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins.孕期接触他汀类药物后不良出生结局评估中的机制与流行病学考量
Am J Med Genet A. 2004 Dec 15;131(3):287-98. doi: 10.1002/ajmg.a.30386.
Zotero 插件